290 related articles for article (PubMed ID: 7936190)
41. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G.
Molino M; Blanchard N; Belmonte E; Tarver AP; Abrams C; Hoxie JA; Cerletti C; Brass LF
J Biol Chem; 1995 May; 270(19):11168-75. PubMed ID: 7744748
[TBL] [Abstract][Full Text] [Related]
42. Implications of the serine protease HtrA1 in amyloid precursor protein processing.
Grau S; Baldi A; Bussani R; Tian X; Stefanescu R; Przybylski M; Richards P; Jones SA; Shridhar V; Clausen T; Ehrmann M
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6021-6. PubMed ID: 15855271
[TBL] [Abstract][Full Text] [Related]
43. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
[TBL] [Abstract][Full Text] [Related]
44. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
[TBL] [Abstract][Full Text] [Related]
45. Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue.
Martins RN; Taddei K; Kendall C; Evin G; Bates KA; Harvey AR
Neuroscience; 2001; 106(3):557-69. PubMed ID: 11591456
[TBL] [Abstract][Full Text] [Related]
46. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor.
Estus S; Golde TE; Kunishita T; Blades D; Lowery D; Eisen M; Usiak M; Qu XM; Tabira T; Greenberg BD
Science; 1992 Feb; 255(5045):726-8. PubMed ID: 1738846
[TBL] [Abstract][Full Text] [Related]
47. Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.
Joachim CL; Duffy LK; Morris JH; Selkoe DJ
Brain Res; 1988 Nov; 474(1):100-11. PubMed ID: 3214703
[TBL] [Abstract][Full Text] [Related]
48. Proteolytic processing of amyloid beta protein precursor (APP) by thrombin.
Igarashi K; Murai H; Asaka J
Biochem Biophys Res Commun; 1992 Jun; 185(3):1000-4. PubMed ID: 1627124
[TBL] [Abstract][Full Text] [Related]
49. Mutation of the gene for the human lysosomal serine protease cathepsin G is not the cause of aberrant APP processing in familial Alzheimer disease.
Wong L; Liang Y; Jiang L; Tsuda T; Fong Q; Galway G; Alexandrova N; Rogaeva E; Lukiw W; Smith J
Neurosci Lett; 1993 Apr; 152(1-2):96-8. PubMed ID: 8515885
[TBL] [Abstract][Full Text] [Related]
50. Limited proteolysis of C1-inhibitor by chymotrypsin-like proteinases.
Schoenberger OL; Sprows JL; Schechter NM; Cooperman BS; Rubin H
FEBS Lett; 1989 Dec; 259(1):165-7. PubMed ID: 2599103
[TBL] [Abstract][Full Text] [Related]
51. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
52. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
53. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
[TBL] [Abstract][Full Text] [Related]
54. Protease "Clipsin" activity and beta-amyloid precursor protein degradation by Alzheimer brain.
Stratmann GC; Webster MT; Bhogal G; Francis PT; Bowen DM
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):241S. PubMed ID: 8224397
[No Abstract] [Full Text] [Related]
55. Variability of beta-amyloid protein deposited lesions in Down's syndrome brains.
Ikeda S; Tokuda T; Yanagisawa N; Kametani F; Ohshima T; Allsop D
Tohoku J Exp Med; 1994 Nov; 174(3):189-98. PubMed ID: 7761984
[TBL] [Abstract][Full Text] [Related]
56. Potential beta PP-processing proteinase activities from Alzheimer's and control brain tissues.
Ladror US; Wang GT; Klein WL; Holzman TF; Krafft GA
J Protein Chem; 1994 May; 13(4):357-66. PubMed ID: 7986341
[TBL] [Abstract][Full Text] [Related]
57. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
58. An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.
Suh YH
J Neurochem; 1997 May; 68(5):1781-91. PubMed ID: 9109502
[TBL] [Abstract][Full Text] [Related]
59. Biotinylated and cysteine-modified peptides as useful reagents for studying the inhibition of cathepsin G.
Brown AM; George SM; Blume AJ; Dushin RG; Jacobsen JS; Sonnenberg-Reines J
Anal Biochem; 1994 Feb; 217(1):139-47. PubMed ID: 8203728
[TBL] [Abstract][Full Text] [Related]
60. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
